Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir

Antiviral Therapy
Won Hyeok ChoeSo Young Kwon

Abstract

The efficacy of entecavir (ETV) monotherapy in treatment-experienced patients with chronic hepatitis B (CHB) is debatable. A total of 22 hepatitis B e antigen (HBeAg)-positive CHB patients who had shown viral breakthrough or suboptimal response with lamivudine (3TC) and adefovir disoproxil (ADV) therapy were treated with 1.0 mg of ETV. Clinical and virological parameters were monitored every 3 months. Restriction fragment mass polymorphism assays were used to detect antiviral resistance. During 3TC and ADV therapy, 11 patients had rtM204V/I mutations, 2 had rtA181V/T or rtN236T, 7 had both and 2 had no 3TC- or ADV-related mutations. After switching to ETV monotherapy, the median change in serum hepatitis B virus (HBV) DNA level was -2.1 log(10) copies/ml. Virological response (HBV DNA<300 copies/ml) was achieved in 1 of 18 patients with pre-existing rt204 mutations, whereas it was achieved in all 4 patients without pre-existing rt204 mutations regardless of the presence of rt181 or rt236 mutations. Changes in mutational patterns during ETV therapy showed that rt204 mutations persisted or re-emerged. Relative abundances of rtM204V/I mutations in total viral populations gradually increased under ETV rescue, whereas those with rtA...Continue Reading

Citations

Jan 18, 2013·World Journal of Gastroenterology : WJG·Zhuo-Lun SongHong Zheng
Sep 22, 2011·Digestive Diseases and Sciences·Myron J TongTruong-Sinh Leduc
Mar 10, 2012·Medicina clínica·Carmen Hidalgo-TenorioFederico García
Mar 29, 2012·Liver International : Official Journal of the International Association for the Study of the Liver·Chang Young SonJun Yong Park
Sep 16, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Lihui Deng, Hong Tang
Jun 12, 2013·Diagnostic Microbiology and Infectious Disease·Zhi-Jun SuZhen-Zhong Lin
Mar 14, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J-H LeeS-O Kim
Feb 27, 2018·Alimentary Pharmacology & Therapeutics·M J TongA D Min
Jul 8, 2010·The Korean Journal of Hepatology·Byeong Uk KimSei Jin Youn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.